Markets
BSE See NSE See 48,732.55
41.75 (0.09%)
Useful Coverage Of Results Season

Useful Coverage Of Results Season

Print

Thank you for covering the results season extensively in the previous issue. It is useful. Are we headed for a recession looking at the disappointing numbers quarter after quarter? - Sandip Kulkarni 

Editor Responds: Thank you for your query. We do not think we are headed for a recession. The slowdown is severe and looks like a cyclical one right now. Normally, any economy comes out of such slowdown by adopting expansionary measures on fiscal and monetary front. 

You may find more insights in our cover story in this issue. Thanking you once again for your query. Keep writing to us.

Comments are only visible to subscribers.

DSIJ Mindshare

Welspun India targets US markets with Target Corporation, board approves buyback & much more!

Geyatee Deshpande / Article rating: 4.5

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

Alembic Pharmaceuticals plunge despite getting USFDA nod for Lurasidone Hydrochloride tablets

Shruti Dahiwal / Article rating: 3.7

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).  

1345Last